« Back Journal of Dermatological Science

Article in Press

Keratinocyte differentiation induced by calcium, phorbol ester or interferon-γ elicits distinct changes in the retinoid signalling pathways

Received 15 June 2009 ,Revised 4 December 2009 ,Accepted 28 December 2009. Published online 12 July 2010 Corrected Proof

References 

  1. Fisher GJ, Voorhees JJ. Molecular mechanisms of retinoid actions in skin. FASEB J. 1996;10:1002–1013
  2. Randolph RK, Simon M. Characterization of retinol metabolism in cultured human epidermal keratinocytes. J Biol Chem. 1993;268:9198–9205
  3. Törmä H, Asselineau D, Andersson E, Martin B, Reiniche P, Chambon P, et al. Biologic activities of retinoic acid and 3,4-didehydroretinoic acid in human keratinocytes are similar and correlate with receptor affinities and transactivation properties. J Invest Dermatol. 1994;102:49–54
  4. Törmä H, Rollman O, Vahlquist A. The vitamin A metabolism and expression of retinoid-binding proteins differ in HaCaT cells and normal human keratinocytes. Arch Dermatol Res. 1999;291:339–345
  5. Chatellard-Gruaz D, Randolph RK, Hagens G, Saurat J-H, Siegenthaler G. Differentiation of human epidermal keratinocytes is accompanied by increased expression of CRABP-II and increased cellular concentration of retinoic acids: retention of newly synthesized retinoic acids by CRABP-II. J Lipid Res. 1998;39:1421–1429
  6. Zouboulis CC, Seltmann H, Sass JO, Ruhl R, Plum C, Hettmannsperger U, et al. Retinoid signaling by all-trans retinoic acid and all-trans retinoyl-β-d-glucuronide is attenuated by simultaneous exposure of human keratinocytes to retinol. J Invest Dermatol. 1999;112:157–164
  7. Pavez Loriè E, Cools M, Borgers M, Wouters L, Shroot B, Hagforsen E, et al. Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis. Br J Dermatol. 2009;160:26–36
  8. Törmä H, Rollman O, Vahlquist A. Detection of mRNA transcripts for retinoic acid, vitamin D3, and thyroid hormone (c-erb-A) nuclear receptors in human skin using reverse transcription and polymerase chain reaction. Acta Derm Venereol. 1993;73:102–107
  9. Reichrath J, Mittmann M, Kamradt J, Muller SM. Expression of retinoid-X receptors (-α,-β,-γ) and retinoic acid receptors (-α,-β,-γ) in normal human skin: an immunohistological evaluation. Histochem J. 1997;29:127–133
  10. Xu XC, Wong WY, Goldberg L, Baer SC, Wolf JE, Ramsdell WM, et al. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis. Cancer Res. 2001;61:4306–4310
  11. Fisher G, Talwar H, Xiao J-H, Datta S, Reddy A, Gaub M-P, et al. Immunological identification and functional quantitation of retinoic acid and retinoid X receptor proteins in human skin. J Biol Chem. 1994;269:20629–20635
  12. Calleja C, Messaddeq N, Chapellier B, Yang H, Kretzel W, Li M, et al. Genetic and pharmacological evidence that a retinoic acid cannot be the RXR-activating ligand in mouse epidermis keratinocytes. Genes Dev. 2006;20:1525–1538
  13. Ghyselinck N, Chambon P. Animal models for retinoid receptor research; implications for epidermal homeostasis, skin barrier function, wound healing and atopic dermatitis. In:  Vahlquist A,  Duvic M editor. Retinoids, carotenoids in dermatology. New York: Informa Healthcare USA Inc.; 2007;p. 27–54
  14. Imakado S, Bickenbach JR, Bundman DS, Rothnagel JA, Attar PS, Wang XJ, et al. Targeting expression of a dominant-negative retinoic acid receptor mutant in the epidermis of transgenic mice results in loss of barrier function. Genes Dev. 1995;9:317–329
  15. Li M, Chiba H, Warot X, Messaddeq N, Gerard C, Chambon P, et al. RXRα ablation in skin keratinocytes results in alopecia and epidermal alterations. Development. 2001;128:675–688
  16. Aneskievich BJ, Fuchs E. The A/B domain of truncated retinoic acid receptors can block differentiation and promote features of malignancy. J Cell Sci. 1995;108:195–205
  17. Berne B, Nilsson M, Vahlquist A. UV irradiation and cutaneous vitamin A: an experimental study in rabbit and human skin. J Invest Dermatol. 1984;83:401–404
  18. Wang Z, Boudjelal M, Kang S, Voorhees JJ, Fisher GJ. Ultraviolet irradiation of human skin causes functional vitamin A deficiency, preventable by all-trans retinoic acid pre-treatment. Nat Med. 1999;5:418–422
  19. Boudjelal M, Wang Z, Voorhees JJ, Fisher GJ. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor γ and retinoid X receptor α in human keratinocytes. Cancer Res. 2000;60:2247–2252
  20. Andersson E, Rosdahl I, Törmä H, Vahlquist A. Differential effects of UV irradiation on nuclear retinoid receptor levels in cultured keratinocytes and melanocytes. Exp Dermatol. 2003;12:563–571
  21. Darwiche N, Celli G, Tennenbaum T, Glick AB, Yuspa SH, De Luca LM. Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors. Cancer Res. 1995;55:2774–2782
  22. Finzi E, Blake MJ, Celano P, Skouge J, Diwan R. Cellular localization of retinoic acid receptor-gamma expression in normal and neoplastic skin. Am J Pathol. 1992;140:1463–1471
  23. Törmä H, Karlsson T, Michaëlsson G, Rollman O, Vahlquist A. Decreased mRNA levels of retinoic acid receptor α, retinoid X receptor α and thyroid hormone receptor α in lesional psoriatic skin. Acta Derm Venereol. 2000;80:4–9
  24. Siegenthaler G, Tomatis I, Didierjean L, Jaconi S, Saurat J-H. Overexpression of cellular retinoic acid binding protein type II (CRABP-II) and down-regulation of CRABP-I in psoriatic skin. Dermatology. 1992;185:251–256
  25. Karlsson T, Virtanen M, Sirsjö A, Rollman O, Vahlquist A, Törmä H. Topical retinoic acid alters the expression of cellular retinoic acid-binding protein-I and cellular retinoic acid-binding protein-II in non-lesional but not lesional psoriatic skin. Exp Dermatol. 2002;11:143–152
  26. Peck GL, DiGiovanna JJ. Synthetic retinoids in dermatology. In:  Sporn MB,  Roberts AB,  Goodman DS editor. The retinoids: biology, chemistry, and medicine. New York: Raven Press; 1994;p. 631–658
  27. Eckert RL, Crish JF, Banks EB, Welter JF. The epidermis: genes on–genes off. J Invest Dermatol. 1997;109:501–509
  28. Brown LJ, Geesin JC, Rothnagel JA, Roop DR, Gordon JS. Retinoic acid suppression of loricrin expression in reconstituted human skin cultured at the liquid–air interface. J Invest Dermatol. 1994;102:886–890
  29. Asselineau D, Bernard BA, Bailly C, Darmon M. Retinoic acid improves epidermal morphogenesis. Dev Biol. 1989;133:322–335
  30. Johansen C, Iversen L, Ryborg A, Kragballe K. 1α,25-dihydroxyvitamin D3 induced differentiation of cultured human keratinocytes is accompanied by a PKC-independent regulation of AP-1 DNA binding activity. J Invest Dermatol. 2000;114:1174–1179
  31. Bikle DD, Gee E, Pillai S. Regulation of keratinocyte growth, differentiation, and vitamin-D metabolism by analogs of 1,25-dihydroxyvitamin D. J Invest Dermatol. 1993;101:713–718
  32. Dlugosz AA, Yuspa SH. Coordinate changes in gene expression which mark the spinous to granular cell transition in epidermis are regulated by protein kinase C. J Cell Biol. 1993;120:217–225
  33. Saunders NA, Jetten AM. Control of growth regulatory and differentiation-specific genes in human epidermal keratinocytes by interferon-γ, Antagonism by retinoic acid and transforming growth factor β1. J Biol Chem. 1994;269:2016–2022
  34. Younus J, Gilchrest BA. Modulation of mRNA levels during human keratinocyte differentiation. J Cell Physiol. 1992;152:232–239
  35. Liu Y, Krueger JG, Bowcock AM. Psoriasis: genetic associations and immune system changes. Genes Immun. 2007;8:1–12
  36. Gaub M-P, Lutz Y, Ghyselinck NB, Scheuer I, Pfister V, Chambon P, et al. Nuclear detection of cellular retinoic acid binding proteins I and II with new antibodies. J Histochem Cytochem. 1998;46:1103–1111
  37. Vollberg TM, Nervi C, George MD, Fujimoto W, Krust A, Jetten AM. Retinoic acid receptors as regulators of human epidermal keratinocyte differentiation. Mol Endocrinol. 1992;6:667–676
  38. Segaert S, Garmyn M, Degreef H, Bouillon R. Suppression of vitamin D receptor and induction of retinoid X receptor α expression during squamous differentiation of cultured keratinocytes. J Invest Dermatol. 2000;114:494–501
  39. Goyette P, Feng Chen C, Wang W, Seguin F, Lohnes D. Characterization of retinoic acid receptor-deficient keratinocytes. J Biol Chem. 2000;275:16497–16505
  40. Kumar R, Shoemaker AR, Verma AK. Retinoic acid nuclear receptors and tumor promotion: decreased expression of retinoic acid nuclear receptors by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis. 1994;15:701–705
  41. Darwiche N, Scita G, Jones C, Rutberg S, Greenwald E, Tennenbaum T, et al. Loss of retinoic acid receptors in mouse skin and skin tumors is associated with activation of the rasHa oncogene and high risk for premalignant progression. Cancer Res. 1996;56:4942–4949
  42. Malek RL, Halvorsen SW. Ciliary neurotrophic factor and phorbol ester each decrease selected STAT3 pools in neuroblastoma cells by proteasome-dependent mechanisms. Cytokine. 1999;11:192–199
  43. Molinari E, Gilman M, Natesan S. Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo. EMBO J. 1999;18:6439–6447
  44. Welter JF, Eckert RL. Differential expression of the fos and jun family members c-fos, fosB, Fra-1, Fra-2, c-jun, junB and junD during human epidermal keratinocyte differentiation. Oncogene. 1995;11:2681–2687
  45. Schug TT, Berry DC, Shaw NS, Travis SN, Noy N. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell. 2007;129:723–733
  46. Aki M, Shimbara N, Takashina M, Akiyama K, Kagawa S, Tamura T, et al. Interferon-γ induces different subunit organizations and functional diversity of proteasomes. J Biochem (Tokyo). 1994;115:257–269
  47. Brysk MM, Selvanayagam P, Arany I, Brysk H, Tyring SK, Rajaraman S. Induction of apoptotic nuclei by interferon-gamma and by predesquamin in cultured keratinocytes. J Interferon Cytokine Res. 1995;15:1029–1035
  48. Widschwendter M, Daxenbichler G, Dapunt O, Marth C. Effects of retinoic acid and γ-interferon on expression of retinoic acid receptor and cellular retinoic acid-binding protein in breast cancer cells. Cancer Res. 1995;55:2135–2139
  49. Delmotte M-H, Tahayato A, Formstecher P, Lefebvre P. Serine 157, a retinoic acid receptorα residue phosphorylated by protein kinase C in vitro, is involved in RXR:RARα heterodimerization and transcriptional activity. J Biol Chem. 1999;274:38225–38231
  50. Horvai AE, Xu L, Korzus E, Brard G, Kalafus D, Mullen TM, et al. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci USA. 1997;94:1074–1079
  51. Ghosh AK, Yuan W, Mori Y, Chen S, Varga J. Antagonistic regulation of type I collagen gene expression by interferon-γ and transforming growth factor-β, Integration at the level of p300/CBP transcriptional coactivators. J Biol Chem. 2001;276:11041–11048

 The work was performed at Uppsala University.

PII: S0923-1811(10)00003-4

doi: 10.1016/j.jdermsci.2009.12.013

« Back Journal of Dermatological Science

Article in Press